Pure Global

Glycated haemoglobin (HbA1c) IVD, control - UK MHRA Medical Device Registration

Glycated haemoglobin (HbA1c) IVD, control is a medical device registered with the UK's Medicines and Healthcare products Regulatory Agency (MHRA) under Device ID 124710. The device is manufactured by Trinity Biotech (Primus Corporation dba Trinity Biotech) from United States, classified as In Vitro Diagnostic Device. The authorized representative in the UK is IVDeology UKRP Ltd.

This page provides comprehensive regulatory information including complete registration details, manufacturer information, device classification, authorized representative details, and related products. Pure Global AI offers free access to 150,962+ UK MHRA medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
MHRA Registered
In Vitro Diagnostic Device
๐Ÿ‡ฌ๐Ÿ‡ง
Glycated haemoglobin (HbA1c) IVD, control
MHRA Device ID: 124710โ€ขRef: 124710

Device Type

In Vitro Diagnostic Device

Devices

Glycated haemoglobin (HbA1c) IVD, control

Type

IVD General

Date Registered

Nov 26, 2024

Last Updated

Jul 9, 2024

Manufacturer Information

Address

4231 E. 75th Terrace

Kansas City, Missouri, United States

Created Date

Dec 20, 2021

Authorized Representative

Relationship Type

UK Responsible Person

Address

Maidstone Innovation Centre Gidds Pond Way

Maidstone, Kent, England, United Kingdom

Postcode: ME14 5FY

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing